Menu Back toSession-1002-Developing-New-Drugs-from-Traditional-Chinese-Medicine-for-Unmet-Public-Health-Needs-II

The 7th DIA China Annual Meeting


Session 1002 Developing New Drugs from Traditional Chinese Medicine for Unmet Public Health Needs - II

Session Chair(s)

Jinhui  Dou

Jinhui Dou

  • Pharmacologist, Botanical Review Team Office of Pharmaceutical Science
  • CDER, FDA, China

TCM Bioinformatics and Post-Metabolism Compounds as Innovative Approaches for New Drug Development

Speaker(s)

Weiguo  Jia

Weiguo Jia

  • Lab Director, Associate Professor
  • Centre for Brain Health, University of British Columbia, Canada, China
E. Dennis  Bashaw, PharmD

1002-2_Dennis Bashaw_Clinical Pharmacology Studies for Botanicals in Different Phases of New Drug Development.pdf

E. Dennis Bashaw, PharmD

  • Senior Science Advisor, Office of Clinical Pharmacology
  • FDA, United States

Contact us

For exhibition, advertising and hosting inquiry, please contact:
Jean XU: jxu@kellencompany.com, or Sofie Peeters: speeters@kellencompany.com
Tel: +86 10 5923 1096

For general inquiry, please contact DIA China office:
dia@diachina.org
Tel: +86 10 5704 2650